Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 904 results for "gsk"

GlaxoSmithKline plc Earns A+ Credit Rating from Morningstar (GSK)

GlaxoSmithKline plc (NYSE:GSK) has been given an A+ credit rating by analysts at Morningstar. The investment research firm's A+ rating indicates that the company is a low default risk. They also gave their stock a three star rating. A number of ... Mideast Time, 21 hours ago

403 images for gsk

Bidness Etc, 2 days ago
Digital Look, 2 days ago
Pharmafocus, 2 days ago
The New Age Online, 1 day ago
Reuters India, 2 days ago
West Australian, 3 days ago
Pharmafocus, 4 days ago
World Industrial Reporter, 1 week ago
Bidness Etc, 6 days ago
The Nation Nigeria, 1 day ago

GSK's phase III study of shingles candidate vaccine, HZ/su meets primary end point

GSK announced that a pivotal phase III study to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles, has met its primary endpoint. Analysis of the primary endpoint showed that HZ/su reduced the risk of shingles ...
 PharmaBiz1 day ago GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results  TheStreet.com2 days ago Glaxo shingles vaccine candidate successful in Phase 3 study  Seeking Alpha3 days ago BRIEF-GSK says shingles vaccine meets primary endpoint in late-stage trial  Reuters3 days ago
[x]  
Marketing-interactive.com

Prashant Pandey is Marketing Director of GSK Consumer Healthcare

Pandey takes over from Jayant Singh who has been given a new role. He has been appointed as the vice president and general manager of GSK Consumer Healthcare Brazil. The changes will come into effect from February 1, 2015. Singh will be ...
 EHealth Magazine1 day ago GSK to launch consumer relations hub in 2015  Marketing-interactive.com3 days ago Prashant Pandey takes over as Marketing Director for GSK Consumer Healthcare Jayant Singh to lead the Brazil business for the company  Agencyfaqs!1 day ago Jayant+Singh+to+lead+the+Brazil+business+for+the+company">Prashant Pandey takes over as Marketing Director for GSK Consumer Healthcare Jayant Singh to lead the Brazil business for the company  Agencyfaqs!5 days ago
[x]  
Pharmafocus

Euro consortium to support Ebola vaccine development

GlaxoSmithKline (GSK) has announced the formation of a new European consortium that will support the firm's development of a new Ebola vaccine. GSK will partner up with researchers from the University of Oxford, Centre Hospitalier Universitaire ...
 Pharma Field3 days ago GSK forms new European consortium to advance Ebola vaccine candidate  Pharmaceutical Technology3 days ago GSK & 3 leading institutions form EU consortium to help further advance development of candidate vaccine against Ebola  PharmaBiz3 days ago GSK Ebola vaccine gets EU support  Pharmafocus4 days ago
Bidness Etc

GSK Shareholders In Favor Of Novartis (NVS) Deal

GlaxoSmithKline plc (ADR) ( NYSE:GSK ) announced that its shareholders voted in overwhelming majority in favor of the company's multi-billion swapping deal with Novartis AG (ADR) ( NYSE:NVS ) in the annual shareholder meeting held on December 18. ...
 Bidness Etc2 days ago GlaxoSmithKline Shareholders Pass Deal With Novartis By Overwhelming Majority  RTTNews.com3 days ago GlaxoSmithKline CEO: Chin up, investors. Dividend's safe, and Novartis deal awaits  FiercePharma2 days ago GSK shareholders approve asset swap deal with Novartis  4 Traders3 days ago
[x]  

Result of General Meeting

Regulatory Story GlaxoSmithKline PLC - GSK Released 12:48 18-Dec-2014 RNS Number : 1952A GlaxoSmithKline PLC 18 December 2014  Issued: Thursday 18 December 2014, London UK - LSE Announcement Result of General Meeting relating to the proposed ...
 London Stock Exchange2 days ago Potential GlaxoSmithKline PLC (GSK) Trade Has 3.75% Downside Protection  Individual.com4 days ago GlaxoSmithKline PLC Result of General Meeting  ADVFN UK3 days ago
Bidness Etc

Salix Pharmaceuticals has the Best Relative Performance in the Pharmaceuticals Industry (SLXP, MDCO, SNY, RPRX, GSK)

(Financial News Network On) We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's ...
 Individual.com4 days ago Riemser Pharma recruits former GSK head  Pharmafocus5 days ago Here's why pharma sector will continue outperforming  Money Control2 months ago Premarket Movers, December 18: Tetraphase Pharmaceuticals Inc (TTPH), Agenus Inc (AGEN), Cerulean Pharma Inc (CERU)  Bidness Etc2 days ago
Motley Fool

3 Beaten Down Stocks Ready to Bounce Back

The stock market in general had a pretty good year in 2014, but not all stocks did so well. GSK fell 17% this year due to falling sales of Advair, the weak debut of its two respiratory drugs, a bribery probe in China, and a stunning swap of its ...
 Austin American Statesman4 days ago Tax-Loss Selling: 1 Stock We'd Be Glad to Sell Right Now  Motley Fool15 hours ago

Agenus: GSK's ZOE-50 Phase 3 Study Meets Primary Endpoint - Quick Facts

Agenus Inc. (AGEN: Quote) announced that its partner GlaxoSmithKline (GSK.L,GSK: Quote) reported that the ZOE-50 Phase 3 study met its primary endpoint. Analysis of the primary endpoint showed that HZ/su reduced the risk of shingles by 97.2 percent ...
 RTTNews.com3 days ago GSK Reports Positive Outcome of Phase III Study of Shingles Vaccine Containing Agenus Adjuvant  PharmaceuticalProcessing2 days ago Positive Outcome of Phase 3 Study of GSK Shingles Vaccine Containing Agenus Adjuvant  EMoneyDaily3 days ago Agenus up on successful outcome of Glaxo Phase 3 shingles vaccine study  Seeking Alpha2 days ago
[x]  

GlaxoSmithKline Reassure Investors That Dividend Is Safe As Analysts Question Payout

GlaxoSmithKline Plc's (GSK) dividend is secure, Chief Executive Officer Andrew Witty said after analysts questioned whether the company could maintain its payout. Glaxo expects to pay a dividend of 80 pence a share for 2014, Witty said in a brief ...
 BioSpace1 day ago Glaxo Says Dividend Is Secure as Analysts Question Payout  BusinessWeek2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less